Foreign and domestic medical device facilities that do not properly renew their registrations with the Food and Drug Administration can be locked out of the U.S. market. Renewals for such facilities are due each year.
Owners or operators of establishments involved in the production and distribution of medical devices intended for commercial distribution in the U.S., including those that are imported for export only, must register annually with the FDA. These facilities include foreign and domestic contract manufacturers, specification developers, relabelers/repackers, and initial importers and foreign exporters. Most such establishments must also list the devices they make.
Failure to submit, renew, update, or cancel a registration can result in import restrictions.
Foreign and domestic medical device facilities, as well as the companies that source from them, should ensure they renew their registrations on time. The current renewal period opens Oct. 1 and will close Dec. 31. Renewals are mandatory regardless of when the initial registration occurred.
FDA Solutions Group offers facility registration services, including identifying a company's registration obligations and potential exemptions and registering foreign or domestic companies, as well as service as a U.S. agent for foreign facilities. To learn more and ensure your company is registered during the renewal period this year, please contact Domenic Veneziano at (202) 734-3939.
Click here to register for ST&R’s Oct. 1 webinar on medical device, food, and cosmetic facility registration requirements.
Copyright © 2026 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.
Related Trade Report Articles
- September 24, 2026 | Trade Report Learn More
Drug Products Exempt from Section 232 Tariffs Defined
Duty Savings, Tariff Mitigation & Supply Chain Efficiencies, Section 232, 301 & Other Trade Remedy Tariff Exclusion Opportunities, Life Sciences
- July 16, 2026 | Trade Report Learn More
FDA Proposes Changes to Foreign Drug Manufacturer Rules
Life Sciences
- May 29, 2025 | Trade Report Learn More
USTR Wants Info on Drug Prices; CBP Warns on Incorrect Import Values
Life Sciences
- February 17, 2023 | Trade Report Learn More
Biological Material Imports are Focus of CBP Guidance
Life Sciences